93 related articles for article (PubMed ID: 15748438)
1. [Expression and its significance of TRAIL and its receptors in cells of patients with acute myeloid leukemia].
Zhao S; Wang HX; Mao H; Xiao J; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):65-9. PubMed ID: 15748438
[TBL] [Abstract][Full Text] [Related]
2. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM
Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284
[TBL] [Abstract][Full Text] [Related]
3. [Apoptosis of acute myeloid leukemic cells induced by human recombinant soluble tumor necrosis factor-related apoptosis inducing ligand (TRAIL)].
Wang HX; Zou P; Zhao S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):766-9. PubMed ID: 15631657
[TBL] [Abstract][Full Text] [Related]
4. [Study of TRAIL receptors expression on the mononuclear cells from multiple myeloma patients and KM3 cells].
Li J; Li JH; Luo SK; Zhao Y; Zhang GC; Zheng D; Tong XZ; Peng AH
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):214-7. PubMed ID: 15949263
[TBL] [Abstract][Full Text] [Related]
5. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2.
Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA
Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967
[TBL] [Abstract][Full Text] [Related]
6. The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells.
Hu JK; Yang K; Li CM; Zhang B; Chen ZX; Chen XZ; Chen JP
Oncol Rep; 2009 Mar; 21(3):681-8. PubMed ID: 19212626
[TBL] [Abstract][Full Text] [Related]
7. DR5 and DcR2 are expressed in human lumbar intervertebral discs.
Chen B; Ma B; Yang S; Xing X; Gu R; Hu Y
Spine (Phila Pa 1976); 2009 Sep; 34(19):E677-81. PubMed ID: 19730199
[TBL] [Abstract][Full Text] [Related]
8. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells.
Kong F; You H; Zhao J; Liu W; Hu L; Luo W; Hu W; Tang R; Zheng K
Virol J; 2015 Nov; 12():192. PubMed ID: 26577955
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia.
Min YJ; Lee JH; Choi SJ; Chi HS; Lee JS; Kim WK; Lee KH
Leuk Res; 2004 Apr; 28(4):359-65. PubMed ID: 15109535
[TBL] [Abstract][Full Text] [Related]
11. Expression of TRAIL and its receptor DR5 and their significance in acute leukemia cells.
Chen SM; Sun H; Liu YF; Ma J; Zhang QT; Zhu J; Li T
Genet Mol Res; 2015 Dec; 14(4):18562-8. PubMed ID: 26782504
[TBL] [Abstract][Full Text] [Related]
12. [The expression of tumor necrosis factor-related apoptosis inducing ligand and its receptors in muscle tissue of inflammatory myopathies].
Zhao H; Wang GC
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):369-73. PubMed ID: 18953943
[TBL] [Abstract][Full Text] [Related]
13. BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia.
Kuroda I; Inukai T; Zhang X; Kikuchi J; Furukawa Y; Nemoto A; Akahane K; Hirose K; Honna-Oshiro H; Goi K; Kagami K; Yagita H; Tauchi T; Maeda Y; Sugita K
Oncogene; 2013 Mar; 32(13):1670-81. PubMed ID: 22665066
[TBL] [Abstract][Full Text] [Related]
14. Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.
Akahane K; Inukai T; Zhang X; Hirose K; Kuroda I; Goi K; Honna H; Kagami K; Nakazawa S; Endo K; Kubota T; Yagita H; Koyama-Okazaki T; Sugita K
Exp Hematol; 2010 Oct; 38(10):885-95. PubMed ID: 20670671
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress inducers, but not imatinib, sensitize Philadelphia chromosome-positive leukemia cells to TRAIL-mediated apoptosis.
Zhang X; Inukai T; Akahane K; Hirose K; Kuroda I; Honna H; Goi K; Kagami K; Tauchi T; Yagita H; Sugita K
Leuk Res; 2011 Jul; 35(7):940-9. PubMed ID: 21466892
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and regional distribution of TRAIL and DR5 on temporomandibular joint discs: comparison of disc derangement with and without reduction.
Leonardi R; Almeida LE; Trevilatto PC; Loreto C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):244-51. PubMed ID: 20123409
[TBL] [Abstract][Full Text] [Related]
17. Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.
Koornstra JJ; Kleibeuker JH; van Geelen CM; Rijcken FE; Hollema H; de Vries EG; de Jong S
J Pathol; 2003 Jul; 200(3):327-35. PubMed ID: 12845629
[TBL] [Abstract][Full Text] [Related]
18. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
Zhu RX; Lin JS; Song YH; Li PY; Tao LW
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):261-4. PubMed ID: 16875623
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
Kong X; Luo J; Xu T; Zhou Y; Pan Z; Xie Y; Zhao L; Lu Y; Han X; Li Z; Liu L
Oncol Rep; 2017 Jun; 37(6):3423-3432. PubMed ID: 28498435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
